Statistics
Publications
8
Citations
889
H-Index
8
Active since
2014
Shriram K. Sundararaman is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and molecular oncology.
Publications per year
2014–2022
8
8
Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer
Shunsuke Kitajima, Elena V. Ivanova, Sujuan Guo et al. · Cancer Discovery · 2018 · 515 citations
MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer
Shunsuke Kitajima, Tetsuo Tani, Benjamin F. Springer et al. · Cancer Cell · 2022 · 101 citations · Full text
Medicine, Cancer Biology, Oncology +11
Tumor-Derived cGAMP Regulates Activation of the Vasculature
Marco Campisi, Shriram K. Sundararaman, Sarah E. Shelton et al. · Frontiers in Immunology · 2020 · 61 citations · Full text
Medicine, Immunology, Oncology +17
Thomas L. Olson, HeeJin Cheon, Jeffrey C. Xing et al. · Blood · 2021 · 59 citations · Full text
Medicine, Hematology, Oncology +12
1–5 of 8